ArticleOncogene2021

ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherapy in lung cancer.

Thaidy Moreno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.